Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital

Children with acute pyelonephritis need medical re-evaluation when home-treated with oral antibiotics

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. Health screening among children newly granted asylum in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Aerosol generation by respiratory support of neonates may be low

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  3. Bronchopulmonary dysplasia predicted at birth by artificial intelligence

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Early prediction of bronchopulmonary dysplasia is possible and important

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  1. Planar scan vs. SPECT/low-dose CT for estimating split renal function by 99mTc-DMSA scintigraphy in children

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Long-term breast-feeding in women with type 1 diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

  • Line Thousig Sehested
  • Konstantinos Kamperis
  • Louise Winding
  • Charlotte Kjaer Bjerre
  • Mette Neland
  • Søren Hagstrøm
  • Line Kønig Wilms
  • Marie Louise Elkjaer Andersen
  • Linda Kuhne-Qvist
  • Jette Skjøde Hoffmann-Petersen
  • Hanne Nørgaard
  • Dina Cortes
Vis graf over relationer

Aim: To investigate the efficacy and safety of home-treatment with oral piv-mecillinam or amoxicillin-clavulanate in children with acute pyelonephritis. Methods: Children aged over 6 months diagnosed with culture confirmed pyelonephritis at Danish Paediatric Departments were home-treated with piv-mecillinam (tablets) or amoxicillin-clavulanate (liquid or tablets). Follow-up was performed by phone (second treatment day) and clinical review of the patients in the hospital (day three). Results: Four hundred eighteen children were included. In total, 333/418 (80%) responded well to the initial oral antibiotic treatment. 85/418 (20%) were changed to another treatment of these 47/418 (11%) to a second-line oral antibiotic and 38/418 (9%) to intravenous antibiotics due to insufficient clinical improvement or bacterial resistance. Bacterial resistance was similar for piv-mecillinam and amoxicillin-clavulanate: 4/74 (5%) versus 33/333 (10%) (p = 0.22). Insufficient clinical improvement, despite no resistance, primarily occurred in children treated with piv-mecillinam: 16/74 (22%) versus 28/344 (8%) (p < 0.001), and predominantly occurred in piv-mecillinam treated children <5 years: 7/20 (35%) versus 9/54 (17%) (p < 0.05), potentially because of problems with piv-mecillinam tablets. In the study population no cases of death or septicemia developed after start of initial oral treatment. Conclusion: A home-treatment regime for pyelonephritis in children >6 months is safe; however, during treatment, clinical re-evaluation is required as in 20% of cases a change in treatment was necessary.

TidsskriftActa paediatrica
Udgave nummer9
Sider (fra-til)2627-2634
Antal sider8
StatusUdgivet - sep. 2021

ID: 65944780